Literature DB >> 26108666

TNAP: a new player in cardiac fibrosis? Focus on "Tissue-nonspecific alkaline phosphatase as a target of sFRP2 in cardiac fibroblasts".

Katherine B Schuetze1, Timothy A McKinsey2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26108666      PMCID： PMC4525085          DOI： 10.1152/ajpcell.00167.2015

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN： 0363-6143            Impact factor:   4.249


× No keyword cloud information.
  10 in total

1.  Exogenously administered secreted frizzled related protein 2 (Sfrp2) reduces fibrosis and improves cardiac function in a rat model of myocardial infarction.

Authors:  Wei He; Lunan Zhang; Aiguo Ni; Zhiping Zhang; Maria Mirotsou; Lan Mao; Richard E Pratt; Victor J Dzau
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-15       Impact factor: 11.205

2.  Aggravation of cardiac myofibroblast arrhythmogeneicity by mechanical stress.

Authors:  Teddy Grand; Nicolò Salvarani; Florian Jousset; Stephan Rohr
Journal:  Cardiovasc Res       Date:  2014-10-24       Impact factor: 10.787

3.  Secreted Frizzled-related protein 2 as a target in antifibrotic therapeutic intervention.

Authors:  Michalis Mastri; Zaeem Shah; Karin Hsieh; Xiaowen Wang; Bailey Wooldridge; Sean Martin; Gen Suzuki; Techung Lee
Journal:  Am J Physiol Cell Physiol       Date:  2013-12-11       Impact factor: 4.249

4.  Diastolic heart failure: evidence of increased myocardial collagen turnover linked to diastolic dysfunction.

Authors:  Ramón Martos; John Baugh; Mark Ledwidge; Christina O'Loughlin; Carmel Conlon; Anil Patle; Seamas C Donnelly; Kenneth McDonald
Journal:  Circulation       Date:  2007-02-05       Impact factor: 29.690

5.  CD73-TNAP crosstalk regulates the hypertrophic response and cardiomyocyte calcification due to α1 adrenoceptor activation.

Authors:  Xiaohong Tracey Gan; Seiichi Taniai; Ganjian Zhao; Cathy X Huang; Thomas J Velenosi; Jenny Xue; Bradley L Urquhart; Morris Karmazyn
Journal:  Mol Cell Biochem       Date:  2014-06-04       Impact factor: 3.396

6.  A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis.

Authors:  Talmadge E King; Williamson Z Bradford; Socorro Castro-Bernardini; Elizabeth A Fagan; Ian Glaspole; Marilyn K Glassberg; Eduard Gorina; Peter M Hopkins; David Kardatzke; Lisa Lancaster; David J Lederer; Steven D Nathan; Carlos A Pereira; Steven A Sahn; Robert Sussman; Jeffrey J Swigris; Paul W Noble
Journal:  N Engl J Med       Date:  2014-05-18       Impact factor: 91.245

7.  Inhibitors of tissue-nonspecific alkaline phosphatase: design, synthesis, kinetics, biomineralization and cellular tests.

Authors:  Julien Debray; Lei Chang; Stéphanie Marquès; Stéphane Pellet-Rostaing; Do Le Duy; Saida Mebarek; René Buchet; David Magne; Florence Popowycz; Marc Lemaire
Journal:  Bioorg Med Chem       Date:  2013-10-17       Impact factor: 3.641

8.  Tissue-nonspecific alkaline phosphatase as a target of sFRP2 in cardiac fibroblasts.

Authors:  Sean Martin; Huey Lin; Chukwuemeka Ejimadu; Techung Lee
Journal:  Am J Physiol Cell Physiol       Date:  2015-05-13       Impact factor: 4.249

9.  Secreted Frizzled-related protein 2 is a procollagen C proteinase enhancer with a role in fibrosis associated with myocardial infarction.

Authors:  Koichi Kobayashi; Min Luo; Yue Zhang; David C Wilkes; Gaoxiang Ge; Thomas Grieskamp; Chikaomi Yamada; Ting-Chun Liu; Guorui Huang; Craig T Basson; Andreas Kispert; Daniel S Greenspan; Thomas N Sato
Journal:  Nat Cell Biol       Date:  2008-12-14       Impact factor: 28.824

10.  Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy.

Authors:  Ankur Gulati; Andrew Jabbour; Tevfik F Ismail; Kaushik Guha; Jahanzaib Khwaja; Sadaf Raza; Kishen Morarji; Tristan D H Brown; Nizar A Ismail; Marc R Dweck; Elisa Di Pietro; Michael Roughton; Ricardo Wage; Yousef Daryani; Rory O'Hanlon; Mary N Sheppard; Francisco Alpendurada; Alexander R Lyon; Stuart A Cook; Martin R Cowie; Ravi G Assomull; Dudley J Pennell; Sanjay K Prasad
Journal:  JAMA       Date:  2013-03-06       Impact factor: 56.272
  10 in total
  2 in total

1.  Tissue-nonspecific alkaline phosphatase as a target of sFRP2 in cardiac fibroblasts.

Authors:  Sean Martin; Huey Lin; Chukwuemeka Ejimadu; Techung Lee
Journal:  Am J Physiol Cell Physiol       Date:  2015-05-13       Impact factor: 4.249

Review 2.  Pharmacologic epigenetic modulators of alkaline phosphatase in chronic kidney disease.

Authors:  Mathias Haarhaus; Dean Gilham; Ewelina Kulikowski; Per Magnusson; Kamyar Kalantar-Zadeh
Journal:  Curr Opin Nephrol Hypertens       Date:  2020-01       Impact factor: 3.416
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.